The role of bronchoplasty in the treatment of lung cancer.
Over a half of the patients with lung cancer have inoperable disease on diagnosis. Limited respiratory reserve due to chronic pulmonary disease can preclude patients from pneumonectomy. A bronchoplastic resection can be used to circumvent pneumonectomy in selected cases. Its applicability in lung cancer was investigated by following up a total of 28 patients who underwent this procedure for lung cancer between 1973 and 1993 in our institution. This was only approximately 1.4% of all our lung cancer operations. The actuarial five-year survival probability was 40%, and the complication rate was 16%. These values are comparable to those reported in the literature and to those of pneumonectomy. It appears that the ideal cases with a proximal tumour but limited disease are rare.
Sioris
T
T
Department of Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Finland.
Salo
J
J
Mattila
S
S
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical / Q000379:methods; D001980:Bronchi / Q000473:pathology / Q000601:surgery*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011013:Pneumonectomy / Q000379:methods*; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D011379:Prognosis; D015996:Survival Rate